Centene Corporation $CNC Shares Bought by Counterpoint Mutual Funds LLC

Counterpoint Mutual Funds LLC increased its stake in Centene Corporation (NYSE:CNC) by 161.1% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 91,943 shares of the company’s stock after acquiring an additional 56,730 shares during the quarter. Centene comprises 0.3% of Counterpoint Mutual Funds LLC’s holdings, making the stock its 10th largest holding. Counterpoint Mutual Funds LLC’s holdings in Centene were worth $3,281,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also recently added to or reduced their stakes in CNC. Baird Financial Group Inc. acquired a new stake in shares of Centene during the first quarter worth $236,000. Sivia Capital Partners LLC grew its holdings in Centene by 80.0% during the 2nd quarter. Sivia Capital Partners LLC now owns 9,710 shares of the company’s stock worth $527,000 after acquiring an additional 4,315 shares during the period. Focus Partners Advisor Solutions LLC raised its position in shares of Centene by 2.1% in the 2nd quarter. Focus Partners Advisor Solutions LLC now owns 23,067 shares of the company’s stock worth $1,252,000 after acquiring an additional 479 shares in the last quarter. Linden Thomas Advisory Services LLC lifted its stake in shares of Centene by 52.1% in the 2nd quarter. Linden Thomas Advisory Services LLC now owns 15,832 shares of the company’s stock valued at $859,000 after purchasing an additional 5,425 shares during the period. Finally, Brighton Jones LLC boosted its position in shares of Centene by 277.5% during the 2nd quarter. Brighton Jones LLC now owns 20,180 shares of the company’s stock valued at $1,095,000 after purchasing an additional 14,835 shares in the last quarter. Institutional investors own 93.63% of the company’s stock.

Analyst Ratings Changes

Several brokerages have issued reports on CNC. Sanford C. Bernstein restated an “outperform” rating and set a $59.00 price target on shares of Centene in a report on Tuesday, January 6th. Oppenheimer reiterated an “outperform” rating and set a $45.00 target price on shares of Centene in a research report on Thursday, October 30th. Barclays set a $44.00 price target on shares of Centene and gave the stock an “equal weight” rating in a report on Tuesday, November 4th. Wall Street Zen cut shares of Centene from a “buy” rating to a “hold” rating in a research report on Sunday, February 15th. Finally, UBS Group set a $42.00 target price on Centene and gave the company a “neutral” rating in a research report on Thursday, October 30th. Three research analysts have rated the stock with a Buy rating, fourteen have given a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $41.88.

Centene Stock Performance

Shares of CNC opened at $43.35 on Tuesday. The firm has a market capitalization of $21.32 billion, a P/E ratio of -3.18, a P/E/G ratio of 0.96 and a beta of 0.48. Centene Corporation has a 52 week low of $25.08 and a 52 week high of $66.03. The stock has a 50 day moving average price of $42.50 and a two-hundred day moving average price of $37.15. The company has a debt-to-equity ratio of 0.87, a quick ratio of 1.10 and a current ratio of 1.10.

Centene (NYSE:CNC) last posted its earnings results on Friday, February 6th. The company reported ($1.19) earnings per share (EPS) for the quarter, topping the consensus estimate of ($1.22) by $0.03. Centene had a negative net margin of 3.43% and a positive return on equity of 4.25%. The firm had revenue of $49.73 billion during the quarter, compared to analyst estimates of $48.41 billion. During the same quarter in the prior year, the business posted $0.80 EPS. The business’s revenue was up 21.9% compared to the same quarter last year. Centene has set its FY 2026 guidance at 3.000-3.000 EPS. Equities analysts forecast that Centene Corporation will post 6.86 earnings per share for the current fiscal year.

Centene Company Profile

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.